PREVENT 10-Year Total CVD Risk (AHA)
Estimates 10-year risk of total cardiovascular disease (atherosclerotic CVD plus heart failure) to guide primary-prevention decisions. Supersedes the Pooled Cohort Equations and does NOT use race.
- Highest activation tier
- Recommended
- How it is scored
- Interactive form only; never scored passively
- Care settings
- Outpatient
When it activates
Scribeable activates a calculator from the encounter. The PREVENT 10-Year Total CVD Risk (AHA) can activate when the transcript or pasted chart context documents any of these:
- Primary prevention cardiovascular risk assessment
- Statin initiation decision
- Hyperlipidemia management
- Cardiovascular risk discussion
- Preventive cardiology evaluation
- Annual wellness visit with lipid review
- New diabetes diagnosis cardiovascular risk
For the PREVENT 10-Year Total CVD Risk (AHA), activation has no note-facing effect: form-only calculators are filtered out of every tier of the drafting guidance, so the draft is neither steered to it nor scored on it. Activation only lists it among the calculators the cockpit offers as an interactive form.
Note-type scope: it activates on notes whose subject resolves to cardiology, emergency medicine, critical care, hospital medicine. A note that resolves to another subject does not carry it even when the clinician's specialty matches; a note with no resolvable subject (a generic consultation) falls back to the specialty match.
Inputs the note needs
14 inputs. These are the interactive form's inputs; none is read from the transcript or chart, and no score is inserted into the note.
| Input | Type | Unit / options | Guidance |
|---|---|---|---|
| Patient age (30-79 years for valid calculation) | age | years | PREVENT is validated for ages 30-79 (the PCE started at 40). |
| Sex | history |
| PREVENT has sex-specific equations. It does NOT use race. |
| Total cholesterol (mg/dL) | lab | mg/dL | Total cholesterol in mg/dL. The model uses non-HDL (total minus HDL) internally. |
| HDL cholesterol (mg/dL) | lab | mg/dL | HDL cholesterol in mg/dL. |
| Systolic blood pressure (mmHg) | vital | mmHg | PREVENT is validated for SBP 90-180 mmHg. |
| Estimated GFR (mL/min/1.73m2) | lab | mL/min/1.73m² | eGFR by the race-free CKD-EPI 2021 equation. New in PREVENT; the PCE did not use kidney function. |
| Body mass index (kg/m2) | vital | kg/m² | BMI in kg/m². New in PREVENT; the PCE did not use it. |
| Currently on antihypertensive treatment | medication | Any antihypertensive medication. | |
| Currently on a statin | medication | New in PREVENT; the PCE did not account for statin use. | |
| Diabetes mellitus | history | Type 1 or type 2 diabetes. | |
| Current smoker | history | CURRENT smoking (not former). | |
| Known clinical ASCVDoptional | history | Prior MI, ACS, revascularization, stroke/TIA, or PAD. PREVENT is for PRIMARY prevention — if yes, the patient is already a secondary-prevention candidate and no risk estimate is needed. | |
| LDL-C >=190 mg/dLoptional | history | LDL-C 190 mg/dL or higher is a statin indication on its own, independent of any calculated risk. | |
| Familial hypercholesterolemia (FH)optional | history | FH warrants high-intensity statin regardless of estimated risk; a low PREVENT score would be actively misleading. |
Interpretation
PREVENT reports THREE 10-year risks: total CVD (atherosclerotic disease plus heart failure), the ASCVD component, and heart failure. Statin and blood-pressure thresholds are defined on the ASCVD component — NOT on total CVD, which is always the larger number. PREVENT also reclassifies roughly half of adults into a lower category than the Pooled Cohort Equations, and treatment thresholds are being revised accordingly (the 2025 AHA/ACC hypertension guideline moved its threshold from 10% to 7.5% for this reason), so a cut-point carried over unchanged from PCE-era guidance will misclassify. Primary prevention only; not validated in established cardiovascular disease.
Evidence
Sources carried in Scribeable's citation registry for this calculator.
- Khan SS, Matsushita K, Sang Y, et al. Development and Validation of the American Heart Association's PREVENT EquationsAHA PREVENT 2024 · 2024 · AHA · AHA Scientific Statement · link last verified 2026-08-31
How Scribeable handles it in the note
Scribeable never scores the PREVENT 10-Year Total CVD Risk (AHA) from a transcript or pasted chart on its own: no computed value is inserted into the draft, surfaced beside it, or checked against a stated one.
It is available as a deliberate interactive form in the web cockpit. You confirm every input yourself, and the result is added to the note only after you review it, because applying this tool is a clinician judgement the chart cannot supply.
Classified as a risk score: activated strictly, by a documented trigger, never by a permissive reading of the encounter.
Score it deliberately on your own encounter
14 days of full Pro. No sales call.
14-day Pro trial with a card on file. $79/month starts 14 days after your trial begins unless you cancel first. Cancel any time from Settings > Billing.